Immune Response to Rotavirus Polypeptides after Vaccination with Heterologous Rotavirus Vaccines (RIT 4237, RRV-1)

References

1. Anderson E. L., Belsche R. B., Bartram J., Crookshanks-Newman F., Chanock R. M., Kapikian A. Z. 1986; Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. Journal of Infectious Diseases 153:823–831
   [Google Scholar]
2. Bastardo J. W., Mckimm-Breschkin J. L., Sonza S., Mercer L. D., Holmes I. 1981; Preparation and characterization of antisera to electrophoretically purified SA-11 virus polypeptides. Infection and Immunity 34:641–647
   [Google Scholar]
3. Clark H. F., Offit P. A., Dolan K. T., Tezza A., Gogalin K., Twist E. M., Plotkin S. A. 1986; Response of adult human volunteers to oral administration of bovine and bovine human reassortant rotaviruses. Vaccine 4:25–31
   [Google Scholar]
4. Delem A., Lobmann M., Zygraich N. 1984; A bovine rotavirus developed as a candidate vaccine for use in humans. Journal of Biological Standardization 12:443–445
   [Google Scholar]
5. Hoshino Y., Wyatt R. G., Greenberg H. B., Flores J., Kapikian A. Z. 1984; Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. Journal of Infectious Diseases 149:694–702
   [Google Scholar]
6. Kapikian A. Z., Midthun K., Hoshino Y., Flores J., Wyatt R. G., Glass R.I., Askaa J., Nakagomi O., Nakagomi T., Chanock R. M., Levine M. M., Clements M. L., Dolin R., Wright P. F., Belshe R. B., Anderson E. L., Potash L. 1985a; Rhesus rotavirus: a candidate vaccine for prevention of human rotavirus disease. In Vaccines ’85 : Molecular and Chemical Basis of Resistance to Viral, Bacterial and Parasitic Diseases pp. 357–367 Lemer R. A., Chanock R. M., Brown F. Edited by New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
7. Kapikian A. Z., Hoshino Y., Flores J., Midthun K., Glass R. I., Nakagomi O., Nakagomi T., Chanock R. M., Potash L., Levine M. M., Dolin R., Wright P. F., Belshe R. E., Anderson E. L., Vesikari T., Gothefors L., Wadell G., Perez-Schael I. 1985b; Alternative approaches to the development of a rotavirus vaccine. Nobel Conference 11. In Development of Vaccines and Drugs against Diarrhoea pp. 192–214 Holmgren J., Lindberg A., Möllby R. Edited by Lund: Studentlitteratur: Bromley: Chartwell-Bratt;
   [Google Scholar]
8. Midthun K., Greenberg H. B., Hoshino Y., Kapikian A. Z., Wyatt R. G., Chancock R. M. 1985; Reassortant rotaviruses as potential live rotavirus vaccine candidates. Journal of Virology 53:949–954
   [Google Scholar]
9. Offit P. A., Clark H F., Plotkin S. A. 1983; Response of mice to rotavirus of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation and plaque reduction neutralization. Infection and Immunity 42:293–300
   [Google Scholar]
10. Offit P. A., Shaw R. D., Greenberg H. B. 1985; Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. Journal of Virology 58:700–703
    [Google Scholar]
11. Offit P. A., Blavat G., Greenberg H. B., Clark H F. 1986; Molecular basis of rotavirus virulence : role of gene segment 4. Journal of Virology 57:46–49
    [Google Scholar]
12. Svensson L., Sheshberadaran H., Vene S., Norrby E., Grandien M., Wadell G. 1987; Serum antibody responses to individual viral polypeptides in human rotavirus infections. Journal of General Virology 68:643–651
    [Google Scholar]
13. Taniguchi K., Urasawa S., Urasawa T. 1985; Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. Journal of General Virology 66:1045–1053
    [Google Scholar]
14. Vesikari T., Isolauri E., Delem A., D’Hondt E., André F. E., Zissis G. 1983; Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet ii:807–811
    [Google Scholar]
15. Vesikari T., Isolauri E, D’Hondt E., Delem A., André F. E., Zissis G. 1984; Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet i:977–981
    [Google Scholar]
16. Vesikari T., Isolauri E., Delem A., D’Hondt E., André F. E., Beards G. M., Flewett T. H. 1985; Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. Journal of Pediatrics 107:189–194
    [Google Scholar]
17. Vesikari T., Kapikian A. Z., Delem A., Zissis G. 1986a; A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. Journal of Infectious Diseases 153:832–839
    [Google Scholar]
18. Vesikari T., Ruuska T., Bogaerts H., Delem A., André F. E. 1986b; Dose response study of RIT 4237 oral rotavirus vaccine in breastfed and formula-fed infants. Pediatric Infectious Diseases 4:622–625
    [Google Scholar]